Royalty Pharma buys royalty rights on biopharmaceutical medicines and receives payments tied to those drugs' sales. It last closed at $68.45 on Nov 20, up 1.08% on the day. The next earnings report for RPRX is expected around Wed, Feb 10, 2027. For the quarter ended Sep 2026, RPRX reported EPS of $0.32 on revenue of $690.1M, with revenue up 13.3% from a year ago. Over its last 8 reports the stock moved an average of 1.8% the session after earnings. Over the last 12 months RPRX insiders bought $0 of stock on the open market and sold $111.1M, according to SEC Form 4 filings.
AI Auto Pilots
Is RPRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RPRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RPRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RPRX · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought
The stock is 1% above its 20 day and 9% above its 50 day average. It is 19% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 63), near overbought. The nearest support is the Pivot at $68.41, and the nearest resistance the Pivot R1 at $68.87.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityNormal, 2.2%/day
Key levels
$70.3752 week high+2.8%
$69.77Swing high (Nov 5)+1.9%
$68.87Pivot R1+0.6%
$68.45Last close
$68.41Pivot−0.1%
$67.99Pivot S1−0.7%
$67.5920 day average−1.3%
$64.84Swing low (Nov 4)−5.3%
$62.3150 day average−9.0%
$60.76100 day average−11.2%
$55.26200 day average−19.3%
$37.3152 week low−45.5%
Indicators
RSI (14)
63.30
Strong, overbought above 70
Neutral
MACD
1.82
Below its signal line
Bearish
Stochastic
62.2
Middle of its range
Neutral
ADX (14)
35.6
Trending up
Williams %R
-34.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
43.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.7%
Change over 10 sessions
Bullish
ATR (14)
$1.49
Typical daily range, 2.2% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityNormal, 4.5%/day
Key levels
$70.3752 week high+2.8%
$69.77Swing high (Nov 5)+1.9%
$68.87Pivot R1+0.6%
$68.45Last close
$68.41Pivot−0.1%
$67.99Pivot S1−0.7%
$67.5920 day average−1.3%
$64.84Swing low (Nov 4)−5.3%
$62.3150 day average−9.0%
$60.76100 day average−11.2%
$55.26200 day average−19.3%
$37.3152 week low−45.5%
Indicators
RSI (14)
71.53
Overbought above 70
Overbought
MACD
4.04
Above its signal line
Bullish
Stochastic
87.9
Near the top of its range
Overbought
ADX (14)
43.3
Strong uptrend
Williams %R
-12.6
Oversold below −80, overbought above −20
Overbought
CCI (20)
162.9
Oversold below −100, overbought above 100
Overbought
Rate of change
+16.8%
Change over 10 sessions
Bullish
ATR (14)
$3.10
Typical daily range, 4.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for RPRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RPRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RPRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RPRXHow many large options trades hit RPRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RPRX in the last 90 days.
From SEC Form 4 filings by RPRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RPRX is in one of them and how their past RPRX trades turned out.
Royalty Pharma buys royalty rights on biopharmaceutical medicines, so it receives payments based on the sales of those drugs. It is based in New York. Its portfolio covers more than 35 marketed therapies across areas such as rare diseases, neuroscience, oncology, immunology and diabetes, along with some development-stage product candidates. Its customers are drug developers, from small and midsize biotechnology companies and academic or research institutions to large global pharmaceutical companies that sell the medicines.